The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure

Abstract Aims Measurement of B‐type natriuretic peptide (BNP) or N‐terminal pro‐BNP is recommended as part of the diagnostic workup of patients with suspected heart failure (HF). We evaluated the diagnostic and prognostic utility of the novel urinary proteomic classifier HF1, compared with BNP, in H...

Full description

Bibliographic Details
Main Authors: Ross T. Campbell, Adam Jasilek, Harald Mischak, Esther Nkuipou‐Kenfack, Agnieszka Latosinska, Paul I. Welsh, Colette E. Jackson, Jane Cannon, Alex McConnachie, Christian Delles, John J.V. McMurray
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12708
_version_ 1818416812475285504
author Ross T. Campbell
Adam Jasilek
Harald Mischak
Esther Nkuipou‐Kenfack
Agnieszka Latosinska
Paul I. Welsh
Colette E. Jackson
Jane Cannon
Alex McConnachie
Christian Delles
John J.V. McMurray
author_facet Ross T. Campbell
Adam Jasilek
Harald Mischak
Esther Nkuipou‐Kenfack
Agnieszka Latosinska
Paul I. Welsh
Colette E. Jackson
Jane Cannon
Alex McConnachie
Christian Delles
John J.V. McMurray
author_sort Ross T. Campbell
collection DOAJ
description Abstract Aims Measurement of B‐type natriuretic peptide (BNP) or N‐terminal pro‐BNP is recommended as part of the diagnostic workup of patients with suspected heart failure (HF). We evaluated the diagnostic and prognostic utility of the novel urinary proteomic classifier HF1, compared with BNP, in HF. HF1 consists of 85 unique urinary peptide fragments thought, mainly, to reflect collagen turnover. Methods and results We performed urinary proteome analysis using capillary electrophoresis coupled with mass spectrometry in 829 participants. Of these, 622 had HF (504 had chronic HF and 118 acute HF) and 207 were controls (62 coronary heart disease patients without HF and 145 healthy controls). The area under the receiver operating characteristic (ROC) curve (AUC) using HF1 for the diagnosis of HF (cases vs. controls) was 0.94 (95% CI, 0.92–0.96). This compared with an AUC for BNP of 0.98 (95% CI, 0.97–0.99). Adding HF1 to BNP increased the AUC to 0.99 (0.98–0.99), P < 0.001, and led to a net reclassification improvement of 0.67 (95% CI, 0.54–0.77), P < 0.001. Among 433 HF patients followed up for a median of 989 days, we observed 186 deaths. HF1 had poorer predictive value to BNP for all‐cause mortality and did not add prognostic information when combined with BNP. Conclusions The urinary proteomic classifier HF1 performed as well, diagnostically, as BNP and provided incremental diagnostic information when added to BNP. HF1 had less prognostic utility than BNP.
first_indexed 2024-12-14T11:56:50Z
format Article
id doaj.art-ef46f42dcbe34cdba9bc08a266064c61
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-14T11:56:50Z
publishDate 2020-08-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-ef46f42dcbe34cdba9bc08a266064c612022-12-21T23:02:06ZengWileyESC Heart Failure2055-58222020-08-01741595160410.1002/ehf2.12708The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failureRoss T. Campbell0Adam Jasilek1Harald Mischak2Esther Nkuipou‐Kenfack3Agnieszka Latosinska4Paul I. Welsh5Colette E. Jackson6Jane Cannon7Alex McConnachie8Christian Delles9John J.V. McMurray10Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre University of Glasgow Glasgow G12 8TA UKRoberson Centre for Biostatistics University of Glasgow Glasgow UKInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre University of Glasgow Glasgow G12 8TA UKMosaiques Diagnostics GmbH Hannover GermanyMosaiques Diagnostics GmbH Hannover GermanyInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre University of Glasgow Glasgow G12 8TA UKQueen Elizabeth University Hospital Glasgow UKHarefield Hospital Harefield London UKRoberson Centre for Biostatistics University of Glasgow Glasgow UKInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre University of Glasgow Glasgow G12 8TA UKInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre University of Glasgow Glasgow G12 8TA UKAbstract Aims Measurement of B‐type natriuretic peptide (BNP) or N‐terminal pro‐BNP is recommended as part of the diagnostic workup of patients with suspected heart failure (HF). We evaluated the diagnostic and prognostic utility of the novel urinary proteomic classifier HF1, compared with BNP, in HF. HF1 consists of 85 unique urinary peptide fragments thought, mainly, to reflect collagen turnover. Methods and results We performed urinary proteome analysis using capillary electrophoresis coupled with mass spectrometry in 829 participants. Of these, 622 had HF (504 had chronic HF and 118 acute HF) and 207 were controls (62 coronary heart disease patients without HF and 145 healthy controls). The area under the receiver operating characteristic (ROC) curve (AUC) using HF1 for the diagnosis of HF (cases vs. controls) was 0.94 (95% CI, 0.92–0.96). This compared with an AUC for BNP of 0.98 (95% CI, 0.97–0.99). Adding HF1 to BNP increased the AUC to 0.99 (0.98–0.99), P < 0.001, and led to a net reclassification improvement of 0.67 (95% CI, 0.54–0.77), P < 0.001. Among 433 HF patients followed up for a median of 989 days, we observed 186 deaths. HF1 had poorer predictive value to BNP for all‐cause mortality and did not add prognostic information when combined with BNP. Conclusions The urinary proteomic classifier HF1 performed as well, diagnostically, as BNP and provided incremental diagnostic information when added to BNP. HF1 had less prognostic utility than BNP.https://doi.org/10.1002/ehf2.12708Heart failureBiomarkersProteomicsCollagenDiagnosisPrognosis
spellingShingle Ross T. Campbell
Adam Jasilek
Harald Mischak
Esther Nkuipou‐Kenfack
Agnieszka Latosinska
Paul I. Welsh
Colette E. Jackson
Jane Cannon
Alex McConnachie
Christian Delles
John J.V. McMurray
The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
ESC Heart Failure
Heart failure
Biomarkers
Proteomics
Collagen
Diagnosis
Prognosis
title The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
title_full The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
title_fullStr The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
title_full_unstemmed The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
title_short The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
title_sort novel urinary proteomic classifier hf1 has similar diagnostic and prognostic utility to bnp in heart failure
topic Heart failure
Biomarkers
Proteomics
Collagen
Diagnosis
Prognosis
url https://doi.org/10.1002/ehf2.12708
work_keys_str_mv AT rosstcampbell thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT adamjasilek thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT haraldmischak thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT esthernkuipoukenfack thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT agnieszkalatosinska thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT pauliwelsh thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT coletteejackson thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT janecannon thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT alexmcconnachie thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT christiandelles thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT johnjvmcmurray thenovelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT rosstcampbell novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT adamjasilek novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT haraldmischak novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT esthernkuipoukenfack novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT agnieszkalatosinska novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT pauliwelsh novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT coletteejackson novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT janecannon novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT alexmcconnachie novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT christiandelles novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure
AT johnjvmcmurray novelurinaryproteomicclassifierhf1hassimilardiagnosticandprognosticutilitytobnpinheartfailure